Lulican XL Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the treatment of superficial fungal infections of the skin such as dermatophytosis, tinea corporis, tinea cruris, and tinea pedis. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The cream formulation allows for effective topical application, ensuring targeted delivery to the site of infection with minimal systemic absorption. Lulican XL Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, with treatment duration varying according to the severity and type of infection, generally ranging from one to two weeks. It is well tolerated, with adverse effects such as mild local irritation, erythema, or itching being infrequent and transient. Lulican XL Cream should be used with caution in patients with known hypersensitivity to luliconazole or any of the cream’s excipients. It is contraindicated in mucosal fungal infections and should not be applied to open wounds or broken skin. Proper adherence to the prescribed regimen is essential to achieve optimal therapeutic outcomes and prevent recurrence.